Literature DB >> 25447624

Hypercalcemic crisis: a clinical review.

Shazia Ahmad1, Gayatri Kuraganti2, Devin Steenkamp3.   

Abstract

Hypercalcemia is a common metabolic perturbation. However, hypercalcemic crisis is an unusual endocrine emergency, with little clinical scientific data to support therapeutic strategy. We review the relevant scientific English literature on the topic and review current management strategies after conducting a PubMed, MEDLINE, and Google Scholar search for articles published between 1930 and June 2014 using specific keywords: "hypercalcemic crisis," "hyperparathyroid crisis," "parathyroid storm," "severe primary hyperparathyroidism," "acute hyperparathyroidism," and "severe hypercalcemia" for articles pertaining to the diagnosis, epidemiology, clinical presentation, and treatment strategies. Despite extensive clinical experience, large and well-designed clinical studies to direct appropriate clinical care are lacking. Nonetheless, morbidity and mortality rates have substantially decreased since early series reported almost universal fatality. Improved outcomes can be attributed to modern diagnostic capabilities, leading to earlier diagnosis, along with the recognition that primary hyperparathyroidism is the most common etiology for hypercalcemic crisis. Hypercalcemic crisis is an unusual endocrine emergency that portends excellent outcomes if rapid diagnosis, medical treatment, and definitive surgical treatment are expedited.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crisis; Emergency; Hypercalcemia; Parathyroid crisis

Mesh:

Year:  2014        PMID: 25447624     DOI: 10.1016/j.amjmed.2014.09.030

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.

Authors:  Andrew J Lowell; Norah M Bushman; Xing Wang; Yue Ma; Susan C Pitt; Rebecca S Sippel; David F Schneider; Reese W Randle
Journal:  J Surg Res       Date:  2017-07-12       Impact factor: 2.192

2.  Concomitant sarcoidosis and papillary thyroid cancer with severe hypercalcaemia as the main symptom.

Authors:  Mikael Groth Riis; Kasper Svendsen Juhl; Jens Meldgaard Bruun
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  [The most frequent electrolyte disorders in the emergency department : what must be done immediately?].

Authors:  B M W Schmidt
Journal:  Internist (Berl)       Date:  2015-07       Impact factor: 0.743

Review 4.  Neurological Complications of Endocrine Emergencies.

Authors:  Salvador Cruz-Flores
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-11       Impact factor: 5.081

Review 5.  Endocrine Emergencies With Neurologic Manifestations.

Authors:  Makoto Ishii
Journal:  Continuum (Minneap Minn)       Date:  2017-06

Review 6.  [Hypercalcemic crisis and hypocalcemic tetany].

Authors:  C Kasperk
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

7.  CLINICAL FEATURES OF HYPERCALCEMIC CRISIS IN PRIMARY HYPERPARATHYROIDISM.

Authors:  U Turan; H Kilavuz; O Irkorucu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

8.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

Review 9.  Hyperthyroidism-associated hypercalcemic crisis: A case report and review of the literature.

Authors:  Ke Chen; Yanhong Xie; Liling Zhao; Zhaohui Mo
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

10.  A rare case of parathyroid crisis with respiratory failure successfully treated using extracorporeal membrane oxygenation.

Authors:  Shunkichi Ikegaki; Takehiro Otoshi; Tomoyuki Hirai; Masataka Hirabayashi
Journal:  Respir Med Case Rep       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.